Moving American Academy of Otolaryngology [?] Head and Neck Surgery Foundation (AAO-HNSF) Guidelines into Practice: The Sudden Hearing Loss (SHL) Guideline

Study ID
STU 022013-056

Cancer Related
No

Healthy Volunteers
No

Study Sites

Contact
Kristy Carter
214-648-3626
kristy.carter@utsouthwestern.edu

Principal Investigator
Peter Roland

Summary

For aim 1, the Main STuDY, descriptive data on SHL patients will be collected. other information to be collected pertains to the condition of the patient once they seek specialty care. The demographics, degree of hearing loss and ear exam findings at time of presentation at the enT along with the patient's prior treatment will be vital to collect. Lastly, an analysis of the variation between the guideline recommendations and the actual practice will be performed.

The patients will be interviewed by the site study coordinator who will capture information on what most patients do as it relates to the typical pathway, timing, and sequence of accessing clinicians after the onset of hearing loss. This interview will be a one-time interaction with verbal approval by the patient if they wish to be interviewed.

For aim 2, the SuB-STuDY, we will explore evidence gaps identified in the development of the Clinical Practice Guideline on Sudden Hearing Loss on a subset of patients with Sudden Sensorineural Hearing Loss (SSHnL). Specifically, we will describe patterns of use and outcomes of four different accepted and practiced steroid treatment options: oral alone, intratympanic (iT) alone, oral and iT combined/simultaneous, oral followed by iT. The steroid treatment is chosen by the provider as standard of care for the patient and is not selected for the purpose of this study.

Those patients that were approached for the Main STuDY may be approached again to participate in the SuB-STuDY if they meet the eligibility criteria of having a diagnosis of sudden sensorineural hearing loss (SSnHL) and who have recently or will be undergoing treatment with steroids (all types). other patients who meet the criteria listed above also will be asked to participate.

For sites that don''t treat their patient population much with steroid treatment, they have the option of opting out of aiM 2, the SuB-STuDY, and not participate.

Participant Eligibility

Aim 1:
1. Symmetrical hearing was present prior to the incident of hearing loss (subjective; no requirement for prior hearing test);
2. Presents with hearing loss in only one ear
3. Non-affected ear can be used as baseline comparator

Aim 2:
1. Diagnosis of sudden sensorineural hearing loss (SSNHL - per definition from AAO-HNSF guideline)
2. Subject has received or will receive steroid treatment for their SSNHL